Fundz Deep Dive
Everything you need to win Tolerance Bio — in one platform.
Who to reach, what to say, and why now on Tolerance Bio — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Tolerance Bio — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Tolerance Bio Raises $17.2 Million in Seed Funding to Increase Healthspan by Adjusting Thymus Function
Oct 20, 2024•over 1 year ago
Contract Type
partnership
PhiladelphiaBiotechnologyHealth CareTherapeuticsDescription
Tolerance Bio, a biopharmaceutical company, has announced the closing of an oversubscribed $17.2 million seed financing round led by Columbus Venture Partners. The company aims to delay and prevent thymic involution and restore thymic function if lost, potentially increasing longevity and addressing immune diseases.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months